Compare price, profitability, solvency, and SEC-reported financials side by side—before deciding which assumptions deserve a closer look.
Decision snapshot: AMCR stock price vs PRGO: inconclusive Relative valuation is incomplete for this pair. Review the available filing metrics before drawing a conclusion.
Quick read
Each company valued on the other's multiple, then compared with the market price.
Implied fair value · at PRGO's multiple
Needs PRGO P/E.
Implied fair value · at AMCR's multiple
Needs EPS (TTM) is negative, AMCR P/E.
Live quote
Price unavailable
Metric by metric
Where each company leads, and how wide the gap is.
Growth edge
Pricing power
Operating leverage
Lower is better
Not comparable
Lower leverage
Statements
Core statements aligned to each company's latest fiscal year.
SEC periods: AMCR FY 2026 (ended Jun 30, 2026) · PRGO FY 2025 (ended Dec 31, 2025). Fiscal years are not aligned.
Trendline
Six fiscal years of revenue, earnings, and margins before underwriting a re-rating.
Price framework
Market cap plus debt, less cash.
Price framework
Discounted free cash flow, then bridged to a per-share price. Same assumptions applied to both companies.
AMCOR PLC · implied price per share
Bear
$18.65
Base
$21.94
Bull
$25.23
Perrigo Company plc · implied price per share
Bear
-$78.20
Base
-$91.99
Bull
-$105.79
Balance sheet health
Financial health checks to separate durable balance sheets from potential value traps.
Financial strength on a 0–9 scale.
Bankruptcy-risk signal from balance sheet and earnings power.
Not enough data to score either balance sheet.
Debt / equity
Total debt against shareholders' equity
1.19x
1.24x
Net debt / EBITDA
Leverage against operating earnings
3.62x
-3.87x
Cash and equivalents
Liquid reserves on the balance sheet
$1.12B
$613.40M
Total debt
Interest-bearing obligations outstanding
$14.00B
$3.64B
Comparable set
Where the pair sits against the wider comparable set.
Keep comparing
Open adjacent comparisons from the same industry to pressure-test the read across multiple pairs.
SONOCO PRODUCTS CO
AMCR vs SON
PACKAGING CORP OF AMERICA
AMCR vs PKG
Avery Dennison Corp
AMCR vs AVY
BALL Corp
AMCR vs BALL
INTERNATIONAL PAPER CO /NEW/
AMCR vs IP
CROWN HOLDINGS, INC.
AMCR vs CCK
TEVA PHARMACEUTICAL INDUSTRIES LTD
AMCR vs TEVA
Organon & Co.
AMCR vs OGN
Hims & Hers Health, Inc.
AMCR vs HIMS
HERBALIFE LTD.
AMCR vs HLF
Live quote
LLM-powered synthesis
An on-demand narrative read of the same deterministic data.
Based on an earlier data snapshot. Review the filing dates below or refresh after signing in.
If you believe AMCR can sustain its positive growth, margins, and cash generation despite leverage, then avoid anchoring on PRGO-implied $2.34 price because PRGO's negative profitability makes the relative valuation unusually distorted.
The valuation gap is extreme: AMCR's current price of $45.00 versus an implied price of $2.34 from the P/S comparison implies -94.8% downside. That said, PRGO set is distorted because PRGO has negative earnings and negative margins, which makes relative valuation on some multiples less informative.
Supporting Metrics
